3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
52
Prostatic Neoplasms
23
Lung Neoplasms
17
Breast Neoplasms
17
Squamous Cell Carcinoma of Head and Neck
14
Stomach Neoplasms
10
Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Urinary Bladder Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Carcinoma, Transitional Cell
6
Triple Negative Breast Neoplasms
5
Non-Muscle Invasive Bladder Neoplasms
5
Carcinoma, Squamous Cell
5
Prostatic Neoplasms, Castration-Resistant
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Endometrial Neoplasms
4
Small Cell Lung Carcinoma
3
Salivary Gland Neoplasms
3
Nasopharyngeal Carcinoma
3
Laryngeal Neoplasms
3
HER2-positive Breast Cancer
3
Fallopian Tube Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma
3
Anatomic Stage I Breast Cancer AJCC v8
3
Adenocarcinoma
3
Vaccinia
2
Interventions
Fulvestrant
4
ribociclib
2
palbociclib
2
Irinotecan
2
Gemcitabine
2
venetoclax
1
tivozanib
1
serabelisib
1
sapanisertib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
cemiplimab
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
STX-478
1
Paclitaxel
1
Metformin
1
Lomustine
1
Letrozole
1
Imlunestrant
1
Doxorubicin
1
Cetuximab
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
Docetaxel
×
90 days
×
Clear all
No trials found.